PRODUCTS

products are part of our comprehensive inventory

COMPANY

employees turning possibilities into reality for people and patients

Explore our diverse pharmaceutical solutions.

Alverin®: Each tablet contains Alverine Citrate BP 60 mg.

Composition

Alverin® is used for the relief of smooth muscle spasm, in conditions such as Irritable Bowel Syndrome (IBS) and primary dysmenorrhoea. It is also indicated in painful diverticular disease of the colon.

Indication

Adults: 60-120 mg 1-3 times daily or as directed by a physician. Not recommended for children under 12 years of age.

Dosage & Administration

Medications that support digestive health and help manage conditions like acid reflux, stomach ulcers, or constipation.

Gastro-intestinal

CURACID® 20Capsule: Each capsule contains Esomeprazole 20 mg as Esomeprazole Magnesium Trihydrate INN. CURACID® 40Capsule: Each capsule contains Esomeprazole 40 mg as Esomeprazole Magnesium Trihydrate INN.

Esomeprazole is indicated for: Gastroesophageal Reflux Disease (GERD): treatment of erosive reflux esophagitis, long-term management of patients with healed esophagitis to prevent relapse, symptomatic treatment of gastroesophageal reflux disease (GERD). In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori: healing of Helicobacter pylori associated duodenal ulcer, prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcer disease.

To treat gastroesophageal reflux disease (GERD) : Adults—20 or 40 milligrams (mg) taken once a day for 4 to 8 weeks. Children up to 18 years of age—Use and dose must be determined by your doctor. To prevent gastroesophageal reflux disease (GERD) : Adults—20 mg taken once a day. Children up to 18 years of age—Use and dose must be determined by your doctor. To treat ulcers related to infection with H. pylori : Adults—40 mg once daily, plus amoxicillin 1000 mg (1 gram) plus clarithromycin 500 mg, taken together before meals twice a day for ten days. Children up to 18 years of age—Use and dose must be determined by your doctor.

Each film coated tablet contains 50 mg Tiemonium methylsulphate INN.

Tiemonium methylsulphate is an antispasmodic drug. It reduces muscle spasms of the intestine;biliary system, uterus &amp; urinary bladder. It is indicated for the pain in gastrointestinal &amp; biliary disease in the urology and gynecology such as gastroenteritis, diarrhoea, dysentery, biliary colic, enterocolitis, cholecystytis, colonopathy, mild cystitis, &amp; spasmodic dysmenorrhoea.

Recommended oral dose of Tiemonium methylsulphate tablet is 2-6 tablets (100-300 mg) daily in divided dosage as required. Pediatric use: Safety and effectiveness of Tiemonium methylsulphate tablets in pediatric patients have not been established. Geriatric use: Efficacy and safety were maintained with increasing age.

Emitof-4 Tablet belongs to the gastro-intestinal therapeutic class and is formulated as an antiemetic medication. Each tablet of Emitof-4 contains 4 mg of Ondansetron, an active ingredient that belongs to a class of drugs known as serotonin 5-HT3 receptor antagonists. The medication is packaged in a size of 3 x 10 tablets, offering a total of 30 tablets per pack.

Emitof-4 Tablet, with Ondansetron 4 mg as its active component, is primarily indicated for the prevention and treatment of nausea and vomiting. This includes nausea and vomiting caused by chemotherapy, radiation therapy, and postoperative nausea and vomiting. Ondansetron works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting.

The dosage of Emitof-4 Tablet should be prescribed based on the specific condition being treated, the patient's age, and overall medical condition. For the prevention of nausea and vomiting associated with chemotherapy and radiation therapy, the usual adult dose is 8 mg administered 30 minutes before treatment, followed by subsequent doses as prescribed. For the prevention of postoperative nausea and vomiting, the typical dose is 4 mg taken 1 hour before the end of surgery. Patients are advised to take Emitof-4 Tablet exactly as prescribed by their healthcare provider. It can be taken with or without food. If a dose is missed, it should be taken as soon as possible; however, if it is almost time for the next dose, the missed dose should be skipped, and the regular dosing schedule resumed. Double dosing should be avoided. It's important for patients to be aware that while Emitof-4 Tablet can help manage nausea and vomiting, it may not completely prevent these symptoms in all cases. Patients should inform their healthcare provider of all medications they are currently taking, as there may be potential interactions. Additionally, any side effects or unusual symptoms experienced while taking Emitof-4 should be reported to a healthcare professional.

Emitof-8 Tablet is categorized in the gastro-intestinal therapeutic class, serving as an antiemetic medication. Each tablet contains 8 mg of Ondansetron, a drug that falls under the class of serotonin 5-HT3 receptor antagonists. This medication is effective in preventing nausea and vomiting. It is available in packs containing 3 strips, each with 10 tablets, amounting to a total of 30 tablets per pack.

Emitof-8 Tablet, with its active ingredient Ondansetron 8 mg, is primarily indicated for the prevention and treatment of nausea and vomiting. This includes nausea and vomiting caused by chemotherapy, radiation therapy, and post-surgical procedures. Ondansetron works by blocking the actions of chemicals in the body that can trigger nausea and vomiting.

The dosage of Emitof-8 Tablet is determined based on the patient's medical condition and response to treatment. For adults undergoing chemotherapy or radiation therapy, the typical dose for preventing nausea and vomiting is 8 mg administered 30 minutes before the start of therapy, followed by subsequent doses as directed by a healthcare provider. For the prevention of postoperative nausea and vomiting, the usual adult dose is 8 mg taken 1 hour before anesthesia. The tablet can be taken with or without food. If a dose is missed, it should be taken as soon as remembered, but if it's near the time for the next dose, the missed dose should be skipped, and the regular dosing schedule should continue. Avoid doubling the dose. Patients should take Emitof-8 Tablet exactly as prescribed by their healthcare provider. While it is effective in managing nausea and vomiting, it might not completely eliminate these symptoms for every patient. It's important to inform the healthcare provider of all current medications to avoid potential interactions. Any side effects or unusual reactions experienced while taking Emitof-8 should be promptly communicated to a healthcare professional.

Freelife Syrup is categorized under the gastro-intestinal therapeutic class, designed as a laxative medication. The active ingredient in this oral solution is Sodium Picosulfate, with each 5 ml of the syrup containing 5 mg of Sodium Picosulfate. This medication is formulated as a 100 ml oral solution. Sodium Picosulfate is a stimulant laxative that works by stimulating the muscles in the bowel, helping to relieve constipation.

Freelife Syrup (Sodium Picosulfate 5mg per 5ml) is primarily indicated for the treatment of constipation. It is effective in providing relief from bowel irregularity and is often used for short-term relief. Additionally, Sodium Picosulfate may be used as a bowel preparation before certain medical procedures or examinations that require a clear bowel, such as colonoscopy.

The dosage of Freelife Syrup should be tailored to the individual patient, depending on the severity of constipation, age, and response to the medication. For adults and children over the age of 10, the usual initial dose is 5-10 mg (5-10 ml of syrup) daily. For children aged 4-10 years, the dose is typically lower and should be specifically prescribed by a healthcare provider. The syrup should be taken at bedtime to produce a bowel movement the following morning. It is important to drink plenty of fluids while taking this medication. The patient should not take the medication for more than a week without consulting a healthcare provider, as prolonged use can lead to dependency or loss of bowel function. Patients should be advised that Freelife Syrup is not intended for long-term use and should be used as directed by a healthcare provider. Any changes in bowel habits, especially if they persist, should be evaluated by a healthcare professional. Patients with specific medical conditions such as inflammatory bowel diseases or severe dehydration should consult a doctor before using this medication.

Freelife Tablet falls within the gastro-intestinal therapeutic class and is a laxative medication. Each tablet contains 10 mg of Sodium Picosulfate, a stimulant laxative that works by directly stimulating the bowel muscles, thereby aiding in bowel movement. The medication is packaged in a size of 5 x 10 tablets, providing a convenient regimen for administration.

Freelife Tablet, with its active ingredient Sodium Picosulfate 10 mg, is primarily indicated for the treatment of constipation. It effectively relieves bowel irregularity and is often used for short-term management of this condition. Additionally, Sodium Picosulfate can be utilized as part of bowel preparation for medical procedures or examinations that require a clear colon, such as colonoscopies.

The dosage of Freelife Tablet should be individualized according to the patient's needs, age, and the severity of constipation. The usual recommended dose for adults and children over 10 years is 10 mg (one tablet) per day. This dosage may be adjusted by a healthcare provider based on the patient’s response to the treatment. It's generally advised to take the tablet at night to produce a bowel movement the following day. Adequate hydration should be maintained during the use of this medication. It is important for patients not to use Freelife Tablet for extended periods (more than a week) without consulting a healthcare professional, as prolonged use may lead to dependency or diminished bowel function. Patients are cautioned that Freelife Tablet is meant for short-term use and should be taken as directed by a healthcare provider. Persistent changes in bowel habits warrant medical evaluation. Furthermore, individuals with specific health conditions like inflammatory bowel diseases or severe dehydration should seek medical advice prior to using this medication.

Lactulose is a synthetic sugar composed of two sugar molecules, galactose, and fructose. It is not absorbed by the body, reaching the colon intact, where it is fermented by bacteria. This fermentation produces organic acids, which draw water into the colon, softening the stool and promoting bowel movements.

Lactulose is primarily used for the treatment of constipation. It is also prescribed for hepatic encephalopathy, a condition associated with liver disease. In hepatic encephalopathy, lactulose helps reduce the levels of ammonia in the colon by promoting the growth of beneficial bacteria that convert ammonia into non-absorbable forms.

The dosage of Lactulose can vary depending on the individual, the condition being treated, and the healthcare provider's recommendations. It is important to follow the prescribed dosage and instructions provided by the healthcare professional. Generally, the oral solution can be taken with or without food, and it is advisable to drink plenty of fluids while using lactulose to prevent dehydration. For constipation, the typical starting dose for adults may be 15-30 ml (1-2 tablespoons) once daily, with adjustments based on individual response. For hepatic encephalopathy, the dosage may be higher and adjusted according to the severity of the condition. It is essential to consult a healthcare professional for personalized advice and guidance on the appropriate dosage and duration of treatment based on your specific health condition.

Normogut® Tablet: Each tblet contains Domperidone Maleate BP equivalent to 10 mg Domperidone. Normogut® Suspension: Each 5 ml suspension contains Domperidone BP 5 mg.

<ol><li>Stimulgut motility in -Non-ulcer dyspepsia -Esophageal reflux, reflux esophagitis and gastritis -Diabetic gation of astroparesis -Functional dyspepsia -Speeding barium transit in follow through radiological studies. </li><li>Prevention and symptomatic relief of acute nausea and vomiting from any cause including cytotoxic therapy, radio therapy and anti-parkinsonism therapy. </li><li>In the prophylactic treatment of migraine.</li></ol>

The recommended oral dose for Adult: 10-20 mg every 4-8 hours daily. Children: 0.2-0.4 mg/kg every 4-8 hours daily. Note: Domperidone should be taken 15-30 minutes before a meal. For acute vomiting and nausea, maximum period of treatment is 12 weeks. Use in children is restricted to nausea and vomiting following cytotoxics or radiotherapy.

Omag-DR®: Each Delayed-release tablet contains Omeprazole Magnesium 20.6 mg equivalent to 20 mg Omeprazole BP.

Treatment of frequent heartburn, defined as 2 or more days per week. Omag-DR® is also indicated in the treatment of conditions where a reduction of gastric acid secretion is required, such as: duodenal ulcer; gastric ulcer; NSAID-associated gastric and duodenal ulcers; reflux esophagitis; symptomatic gastroesophageal reflux disease (GERD); dyspepsia; Zollinger-Ellison syndrome (pathological hypersecretory condition); eradication of H. pylori. Omag-DR®, in combination with Clarithromycin, Amoxicillin and Metronidazole, is indicated for the treatment of patients with peptic ulcer disease associated with H. pylori infection.

Adults: One tablet taken once daily with a full glass of water 15-60 minutes before eating the first meal of the day for 14 consecutive days. Patients should not continue therapy beyond 14 days unless directed to do so by a physician. The course of therapy can be repeated once every 4 months Children: The safety and effectiveness of Omeprazole Magnesium tablets in children have not been established.

Pantocure™ 20 Tablet: Each tablet contains Pantoprazole Sodium Sesquihydrate BP equivalent to Pantoprazole 20 mg.

Benign gastric ulcer, duodena l ulcer, gastroesophageal reflux disease (GERD), NSAID-induced peptic ulcer, acid hypersecretory conditions including Zollinger - Ellison Syndrome, eradication of Helicobacter pylori (in combination with antibiotics), ulcer resistant to H2 receptor antagonists

For benign gastric ulcer and duodenal ulcer, the recommended dosage is 40 mg daily in the morning for 4 weeks, with the option to continue for an additional 4 weeks if the ulcer is not fully healed. In cases of NSAIDs induced peptic ulcer, a daily dosage of 20 mg is advised. For acid hypersecretory conditions, including Zollinger-Ellison Syndrome, the initial dose is 80 mg once daily, which can be adjusted based on the patient's response. However, for elderly patients, the maximum daily dose is 40 mg, and doses above 80 mg are divided into two administrations. The eradication of Helicobacter pylori requires 40 mg twice daily in combination with antibiotics. For ulcers resistant to H2 receptor antagonists, a maintenance therapy of 20 mg daily is recommended and can be increased to 40 mg daily if symptoms recur. Lastly, for gastroesophageal reflux disease (GERD), the recommended daily dose ranges from 20 to 40 mg in the morning, and the treatment may continue for an additional 4 weeks if necessary to achieve full healing.

PREVENCID ® 20 Capsule: Each capsule contains Omeprazole BP 20 mg PREVENCID® 40 Capsule: Each capsule contains Omeprazole BP 40 mg

Benign gastric and duodenal ulcers including those complicating NSAID therapy, erosive reflux esophagitis and for disorders associated with hypersecretion of gastric acid, such as the Zollinger Ellison syndrome.

Benign gastric and duodenal ulcers including those complicating NSAID therapy: 20 mg daily for 4 weeks in duodenal ulceration or 8 weeks in gastric ulceration, in severe cases the dose may be increased to 40 mg daily, long-term use is not recommended. Healing of reflux esophagitis: 20 mg daily for 4 weeks, followed by a further 4-8 weeks if not fully healed, 40 mg daily has been given for 8 weeks in reflux esophagitis refractory to other treatment; may be continued at 20 mg daily. Zollinger-Ellison syndrome: Initially 60 mg once daily; usual range 20-120 mg daily (above 80 mg in 2 divided doses). Larger doses up to 180 mg daily in divided doses may be used or as prescribed by the physicians.

Digestive system medications, ranging from antacids and antiemetics to laxatives and probiotics, address conditions such as acid reflux, nausea, constipation, and bacterial infections. Professional guidance is essential for accurate diagnosis and proper use of these medications.

Digestive System Health

We believe
any illness
has remedy.